Why the study?
Current methods for diagnosing lymphocytic myocarditis on endomyocardial biopsy lead to inconsistent diagnoses, prompting a revision of criteria to address shortcomings of the Dallas and ESC criteria.
The "Seaport" criteria provide a standardized, consensus-based histopathologic framework using CD3 immunohistochemistry to improve the diagnosis and classification of lymphocytic myocarditis on endomyocardial biopsy.
Answers are grounded in this paper and cite their sources.
Adopts Seaport criteria to standardize lymphocytic myocarditis diagnosis on EMB; extends prior approaches with CD3 IHC grading and SITUS category.
BACKGROUND AND AIM: Lymphocytic myocarditis has long been appreciated as a lymphocyte-predominant myocardial inflammation with resultant myocyte injury. However, current methods of diagnosis on endomyocardial biopsy (EMB) lead to inconsistent diagnoses. To improve patient care, the criteria for the diagnosis of lymphocytic myocarditis on endomyocardial biopsies have been revised to address shortcomings of the Dallas Criteria and European Society of Cardiology (ESC) criteria. METHODS AND RESULTS: In the Seaport area of Boston, a panel of expert cardiovascular pathologists from the Society for Cardiovascular Pathology (SCVP) and the Association for European Cardiovascular Pathology (AECVP) completed a three-year project to develop consensus terms and definitions. These "Seaport" criteria for EMB were developed to utilize CD3 immunohistochemistry for T lymphocytes and accurately define each level of histopathologic severity based on extent of infiltrate and presence of myocyte injury. These criteria create a diagnostic approach to lymphocytic myocarditis using three grades of severity (mild, moderate, and severe) along with a category of scattered increased T lymphocytes of undetermined significance (SITUS). The document discusses the role of ancillary studies, the relationship to other diagnostic modalities, and areas of continuing controversy in the development of these criteria. CONCLUSION: These consensus-based criteria offer a standardized framework for diagnosing lymphocytic myocarditis in EMB. Adoption of these easy-to-use criteria will improve classification of lymphocytic myocarditis as an aid to diagnose and treat patients.
No takes yet. Share an insight, caveat, or question.
Halushka et al. (2025) conducted a review in Lymphocytic myocarditis. Seaport criteria was evaluated on Standardized framework for diagnosing lymphocytic myocarditis. The Seaport criteria provide a standardized framework utilizing CD3 immunohistochemistry to classify lymphocytic myocarditis severity into 3 grades (mild, moderate, severe) and SITUS.
Synapse has enriched 10 related papers. Consider them for comparative context: